Genetic

Lilly Acquires Hearing Loss Specialist Akouos

Lilly has agreed to acquire Akouos, a precision genetic medicine company that is developing gene therapy treatments for hearing loss. Both companies’ boards have approved the deal, which is expected to close in the fourth quarter and cost Lilly up to $610 million.

UK and US Scientists See no Harm in GM

The Art of the Alliance

The Future Lies in the Genome

Dow to Restrict GM Corn, Soybeans Sales Pending Chinese OK